Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.37 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.37 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.35 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.35 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31093004 | 0.90 | SLC6A4 (0.49) | SLC6A3SLC6A4ALDH1A1KMT2AGFER | |
| SCHEMBL9779110 | 0.80 | ALDH1A1 (0.65) | SLC6A3SLC6A4ALDH1A1KMT2AGFER | |
| SCHEMBL1903553 | 0.78 | ALDH1A1 (0.62) | SLC6A3SLC6A4ALDH1A1KMT2AGFER | |
| SCHEMBL31093170 | 0.74 | SLC6A4 (0.69) | SLC6A3SLC6A4ALDH1A1KMT2AGFER | |
| SCHEMBL31093052 | 0.73 | SLC6A4 (0.43) | SLC6A3SLC6A4ALDH1A1KMT2AGFER | |
| SCHEMBL31093121 | 0.72 | SLC6A4 (0.62) | SLC6A3SLC6A4ALDH1A1KMT2AGFER | |
| SCHEMBL31093199 | 0.71 | SLC6A4 (0.57) | SLC6A3SLC6A4ALDH1A1KMT2AGFER | |
| SCHEMBL9779048 | 0.71 | CHRNB2 (0.53) | ALDH1A1KMT2AGFERHPGDCHRNB2 | |
| SCHEMBL7990104 | 0.69 | MAOA (0.56) | SLC6A3SLC6A4ALDH1A1KMT2AHPGD | |
| SCHEMBL5597945 | 0.69 | CHRNB2 (0.50) | SLC6A3SLC6A4ALDH1A1KMT2AGFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035497-A1 | AMINE CONTAINING COPOLYMERS VIA EMULSION POLYMERIZATION AND METHODS OF USE THEREOF | INFINEUM INTERNATIONAL LIMITED (US) | 2026-02-05 | — | — | US | claimed |
| US-20260035493-A1 | AMINE CONTAINING COPOLYMERS VIA RADICAL POLYMERIZATION AND METHODS OF USE THEREOF | INFINEUM INTERNATIONAL LIMITED (US) | 2026-02-05 | — | — | US | claimed |
| US-20260028457-A1 | AMINE CONTAINING COPOLYMER EMULSION COMPOSITIONS AND METHODS OF MAKING AND USE THEREOF | INFINEUM INTERNATIONAL LIMITED (US) | 2026-01-29 | — | — | US | claimed |
| US-20250250379-A1 | AMINE CONTAINING POLYMER COMPOSITIONS AND USES THEREOF | INFINEUM INTERNATIONAL LIMITED (US) | 2025-08-07 | — | — | US | claimed |
| EP-4596661-A1 | AMINE CONTAINING POLYMER COMPOSITIONS AND USES THEREOF | Infineum International Limited (GB) | 2025-08-06 | — | — | EP | claimed |
| US-20240287009-A1 | AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME | INFINEUM INTERNATIONAL LIMITED (GB) | 2024-08-29 | — | — | US | claimed |
| EP-4410772-A2 | AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME | Infineum International Limited (GB) | 2024-08-07 | — | — | EP | claimed |
| CN-118440229-A | Amine functional monomers and methods of making the same | 英菲诺姆国际有限公司 | 2024-08-06 | — | — | CN | claimed |
| US-20260035495-A1 | FUNCTIONAL COPOLYMERS AND METHODS OF PREPARATION THEREOF | Kraton Corporation (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260035497-A1 | AMINE CONTAINING COPOLYMERS VIA EMULSION POLYMERIZATION AND METHODS OF USE THEREOF | INFINEUM INTERNATIONAL LIMITED (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260035493-A1 | AMINE CONTAINING COPOLYMERS VIA RADICAL POLYMERIZATION AND METHODS OF USE THEREOF | INFINEUM INTERNATIONAL LIMITED (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260028457-A1 | AMINE CONTAINING COPOLYMER EMULSION COMPOSITIONS AND METHODS OF MAKING AND USE THEREOF | INFINEUM INTERNATIONAL LIMITED (US) | 2026-01-29 | — | — | US | disclosed |
| US-20250250379-A1 | AMINE CONTAINING POLYMER COMPOSITIONS AND USES THEREOF | INFINEUM INTERNATIONAL LIMITED (US) | 2025-08-07 | — | — | US | disclosed |
| EP-4596661-A1 | AMINE CONTAINING POLYMER COMPOSITIONS AND USES THEREOF | Infineum International Limited (GB) | 2025-08-06 | — | — | EP | disclosed |
| US-20240287009-A1 | AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME | INFINEUM INTERNATIONAL LIMITED (GB) | 2024-08-29 | — | — | US | disclosed |
| EP-4410772-A2 | AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME | Infineum International Limited (GB) | 2024-08-07 | — | — | EP | disclosed |
| CN-118440229-A | Amine functional monomers and methods of making the same | 英菲诺姆国际有限公司 | 2024-08-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035495-A1 | FUNCTIONAL COPOLYMERS AND METHODS OF PREPARATION THEREOF | VCL, FGB, CDH1 | SLC6A3 3824/4885SLC6A4 4190/4885ALDH1A1 303/4885 |
| US-20260035493-A1 | AMINE CONTAINING COPOLYMERS VIA RADICAL POLYMERIZATION AND METHODS OF USE THEREOF | CBS, SELP, RAD51 | SLC6A3 1604/4885SLC6A4 967/4885ALDH1A1 813/4885 |
| US-20240287009-A1 | AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME | AMD1, HNMT, MAT1A | SLC6A3 2219/4885SLC6A4 2274/4885ALDH1A1 317/4885 |
| US-20260035497-A1 | AMINE CONTAINING COPOLYMERS VIA EMULSION POLYMERIZATION AND METHODS OF USE THEREOF | DEGS1, SGMS1, PHOSPHO1 | SLC6A3 3038/4885SLC6A4 2459/4885ALDH1A1 2406/4885 |
| US-20260028457-A1 | AMINE CONTAINING COPOLYMER EMULSION COMPOSITIONS AND METHODS OF MAKING AND USE THEREOF | DEGS1, PHOSPHO1, NAPEPLD | SLC6A3 2986/4885SLC6A4 3112/4885ALDH1A1 2211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.